EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis

Zhenxiong Zhao, Hui Sun, Yingxue Liu, Yanqiu Zhang, Xin Wang, Xu Wang, Cong Tan, Shujuan Ni, Weiwei Weng, Meng Zhang, Lei Wang, Dan Huang und 4 weitere

MedComm · 2025-01 · 6 (1)

DOI: 10.1002/mco2.70037 ↗

Kurz gefasst

Fachartikel in der Zeitschrift MedComm, online erschienen am 06.01.2025. Verfasst von Zhenxiong Zhao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery Fudan University Shanghai Cancer Center Shanghai China. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer‐associated fibroblasts (CAFs) are intrinsic components of the tumor microenvironment that promote cancer progression and metastasis. Through an unbiased integrated analysis of gastric tumor grade and stage, we identified a subset of proangiogenic CAFs characterized by high podoplanin (PDPN) expression, which are significantly enriched in metastatic lesions and secrete chemokine (CC‐motif) ligand 2 (CCL2). Mechanistically, PDPN(+) CAFs enhance angiogenesis by activating the AKT/NF‐κB signaling pathway. The canonical NF‐κB signaling protein P65 binds to the promoter region of CCL2, inducing its expression. Additionally, we found that CCL2 interacts with its nonclassical receptor ACKR1 (expressed on endothelial cells) to exert its proangiogenic effects. Furthermore, the disruption of CCL2‐ACKR1 communication via a CCL2 neutralizing antibody or the inhibition of AKT signaling transduction using AKT inhibitors effectively suppressed tumor growth. Together, this study elucidates the mechanism by which PDPN(+) CAFs promote angiogenesis, providing a deeper understanding of the molecular processes underlying CAF‐mediated angiogenesis and suggesting potential therapeutic targets for gastric cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

CCL2PDPNangiogenesiscancer‐associated fibroblastsgastric cancer

Autor:innen und Institutionen

  • Department of Gastric Surgery Fudan University Shanghai Cancer Center Shanghai China.
  • Department of Oncology Shanghai Medical College, Fudan University Shanghai China.
  • Department of Pathology Fudan University Shanghai Cancer Center Shanghai China.
  • Institute of Pathology Fudan University Shanghai China.
  • Department of Endoscopy Fudan University Shanghai Cancer Center Shanghai China.
  • Department of Artificial Intelligence Medicine, Graduate School of Medicine Chiba University Chiba Japan.

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Zhao, Z., Sun, H., Liu, Y., Zhang, Y., Wang, X., Wang, X., Tan, C., Ni, S., Weng, W., Zhang, M., Wang, L., Huang, D., Gu, W., Chang, J., Sheng, W., & Xu, M. D. (2025). PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis. MedComm, 6(1). https://doi.org/10.1002/mco2.70037

Vancouver

Zhao Z, Sun H, Liu Y, Zhang Y, Wang X, Wang X, et al. PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis. MedComm. 2025;6(1). doi:10.1002/mco2.70037

BibTeX
@article{Zhao2025,
  author = {Zhao, Zhenxiong and Sun, Hui and Liu, Yingxue and Zhang, Yanqiu and Wang, Xin and Wang, Xu and Tan, Cong and Ni, Shujuan and Weng, Weiwei and Zhang, Meng and Wang, Lei and Huang, Dan and Gu, Wenchao and Chang, Jinjia and Sheng, Weiqi and Xu, Mi-Die},
  title = {PDPN+ cancer‐associated fibroblasts enhance gastric cancer angiogenesis via AKT/NF‐κB activation and the CCL2‐ACKR1 axis},
  journal = {MedComm},
  year = {2025},
  volume = {6},
  number = {1},
  doi = {10.1002/mco2.70037}
}
Kostenlos starten →